OM
IDYA icon

Opaleye Management’s IDEAYA Biosciences IDYA Stock Holding History

Opaleye Management’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-311,500
Closed -$11.1M – 55
2023
Q4 		$11.1M Hold
311,500
– – 2.95% 8
2023
Q3 		$8.4M Sell
311,500
-103,500
-25% -$2.62M 2.73% 11
2023
Q2 		$9.75M Buy
415,000
+72,000
+21% +$1.48M 2.33% 9
2023
Q1 		$4.71M Buy
343,000
+204,200
+147% +$3.4M 1.41% 24
2022
Q4 		$2.52M Buy
138,800
+137,300
+9,153% +$2.31M 0.88% 33
2022
Q3 		$22K Buy
+1,500
New +$19.5K 0.01% 41

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Opaleye Management's IDYA Position: Q1 2024 in Review

Opaleye Management sold out of IDEAYA Biosciences (IDYA) in Q1 2024, closing a stake of 311,500 shares — an estimated $11.1M sold.

Opaleye Management first reported a position in IDYA in Q3 2022 and held it in 6 quarters. The position peaked at $11.1M in Q4 2023. 204 funds tracked by Wall St. Rank hold IDYA as of Q1 2024.

  • Opaleye Management reported no remaining IDEAYA Biosciences position as of Q1 2024 after selling out during the quarter.
  • Opaleye Management sold 311,500 IDEAYA Biosciences shares in Q1 2024, an estimated $11.1M.
  • Opaleye Management first reported a position in IDEAYA Biosciences in Q3 2022 and held it in 6 quarters.
  • Opaleye Management's IDEAYA Biosciences position peaked at $11.1M in Q4 2023.
  • 204 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q1 2024.

Based on Opaleye Management's 13F filing for Q1 2024, filed 15 May 2024.